KYPHA
Kypha is an early-stage life sciences company developing leading-edge technology and clinically useful products to improve the way autoimmune and inflammatory disorders are monitored and treated. With a core team of nine, plus an extensive network of scientific advisors, clinical collaborators and business mentors, Kypha has leveraged Federal grants and raised more than $3 million in private capital since 2011 to advance its lead diagnostic product – Comp Act Dx – toward FDA clearance and co... mmercial launch in early 2014. Comp Act Dx is a simple yet revolutionary test that quickly measures the level of inflammation in the body – such as that caused by traumatic injury or autoimmune disease – with an unprecedented combination of speed and accuracy. Comp Act Dx is designed to allow superior monitoring of at-risk patients by measuring changes in inflammation in near-real time, thereby aiding medical professionals in making earlier, more effective clinical intervention decisions.
KYPHA
Industry:
Biotechnology Health Care Medical Device
Founded:
2009-01-01
Address:
Saint Louis, Missouri, United States
Country:
United States
Website Url:
http://www.kypha.net
Total Employee:
1+
Status:
Active
Contact:
314-282-2008
Total Funding:
24.01 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics
Similar Organizations
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Current Employees Featured
Chad Stiening CEO @ Kypha
CEO
Paul Olson PRESIDENT & CSO @ Kypha
PRESIDENT & CSO
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-07-13 | Biosensia | Biosensia acquired by Kypha | N/A |
Investors List
Arsenal Capital Management
Arsenal Capital Management investment in Series A - Kypha
BioGenerator
BioGenerator investment in Venture Round - Kypha
Arsenal Capital Management
Arsenal Capital Management investment in Venture Round - Kypha
Serra Ventures
Serra Ventures investment in Venture Round - Kypha
Serra Ventures
Serra Ventures investment in Venture Round - Kypha
Serra Ventures
Serra Ventures investment in Venture Round - Kypha
Serra Ventures
Serra Ventures investment in Debt Financing - Kypha
Serra Ventures
Serra Ventures investment in Convertible Note - Kypha
BioGenerator
BioGenerator investment in Venture Round - Kypha
Arsenal Capital Management
Arsenal Capital Management investment in Venture Round - Kypha
Official Site Inspections
http://www.kypha.net
- Host name: 108-167-141-213.unifiedlayer.com
- IP address: 108.167.141.213
- Location: Houston United States
- Latitude: 29.8284
- Longitude: -95.4696
- Metro Code: 618
- Timezone: America/Chicago
- Postal: 77092
More informations about "Kypha"
Kypha: Redefining and solving unmet needs in immune …
Kypha is an immune insights company delivering solutions that improve therapeutic development and clinical care for patients with immune-related conditions. 4340 Duncan Ave, Suite 204 St. …See details»
ABOUT US - Kypha
Kypha is an immune insights company delivering solutions that improve therapeutic development and clinical care for patients with immune-related conditions. 4340 Duncan Ave, Suite 204 St. …See details»
Kypha - Crunchbase Company Profile & Funding
Contact Email info@kypha.net Phone Number 314-282-2008 Kypha is an early-stage life sciences company developing leading-edge technology and clinically useful products to improve the way autoimmune and inflammatory disorders …See details»
Kypha - LinkedIn
Kypha’s mission is to enable and deliver precise, real-time information from complement, the most inaccessible element of the innate immune system.See details»
Kypha Company Profile 2024: Valuation, Funding & Investors
Kypha General Information Description. Developer in-vitro diagnostic biomarker tests intended to monitor immune system activity. The company's platform facilitates testing at scale from home …See details»
Kypha - Overview, News & Similar companies | ZoomInfo.com
Dec 19, 2018 View Kypha (www.kypha.net) location in Missouri, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
PARTNERING SOLUTIONS - Kypha
Kypha is an immune insights company delivering Precision Immune Monitoring (PIM) solutions to improve therapeutic development and clinical care for patients with immune-related conditions. …See details»
Kypha - LinkedIn
Kypha | 482 followers on LinkedIn. Precision Immune Monitoring Delivered | Kypha’s mission is to enable and deliver precise, real-time information from complement, the most inaccessible …See details»
Biosensia - LinkedIn
Biosensia | 1,334 followers on LinkedIn. Biosensia is Kypha Company based in Dublin, Ireland. Developing Point-of-Care in-vitro diagnostics.See details»
Kypha - Funding, Financials, Valuation & Investors - Crunchbase
Kypha is funded by 7 investors. Arsenal Capital Management and BioGenerator are the most recent investors. Kypha has a post-money valuation in the range of $10M to $50M as of Dec …See details»
Kypha - M&A Summary and Business Overview - Mergr
Kypha is a clinically focused diagnostics company developing, validating and commercializing specialized biomarker testing capable of providing reliable and timely results in any clinical …See details»
Kypha Secures $4M Series A Funding to Accelerate First-in-Class ...
Dec 20, 2018 For more information on Kypha and to see the passion that's driving this company, visit kypha.net . About Kypha: Kypha is a clinically focused diagnostics company developing, …See details»
OUR SYSTEMS - Kypha
Kypha is an immune insights company delivering solutions that improve therapeutic development and clinical care for patients with immune-related conditions. 4340 Duncan Ave, Suite 204 St. …See details»
Martin J. Schmidt - Principal and Founder - MJS Bioscience LLC
Leading Kypha's clinical development and partnering strategy to support pipeline development, commercialization, and adoption of complement split product diagnostics for inflammatory and ...See details»
Kypha Secures $4M Series A Funding to Accelerate First-in
Dec 20, 2018 ST LOUIS, /PRNewswire/ -- Kypha, a medical diagnostics company with an innovative testing platform for precision monitoring of immune system activity to improve …See details»
Kypha: Contact Us
Kypha is an immune insights company delivering Precision Immune Monitoring (PIM) solutions to improve therapeutic development and clinical care for patients with immune-related conditions. …See details»
Kypha Acquires Biosensia - Expands First-in-Class Immune Status ...
Jul 13, 2018 For more information on Kypha and to see the passion that's driving this company, visit kypha.net . Media Contact: Martin J. Schmidt, PhD [email protected] 314-282-2008. About …See details»
Kypha | EquityNet
Kypha is an early-stage life sciences company developing leading-edge technology and clinically useful products to improve the way autoimmune and inflammatory disorders are monitored …See details»
Kypha acquires Biosensia—expands first-in-class immune status ...
Kypha, a medical diagnostics company developing specialized biomarker testing solutions for precision monitoring of immune status and inflammation, has acquired Biosensia, a …See details»
PRIVACY POLICY - Kypha
Jul 10, 2018 Kypha is an immune insights company delivering Precision Immune Monitoring (PIM) solutions to improve therapeutic development and clinical care for patients with immune …See details»